Abnormally phosphorylated protein tau in the cortex of aged individuals of various mammalian orders

Acta Neuropathologica

Volumn 100, Issue 3, 2000, Pages 305-312

  Härtig, Wolfgang ^a   Klein, Christina ^a   Brauer, Kurt ^a   Schüppel, Karl Friedrich ^a   Arendt, Thomas ^a   Brückner, Gert ^a   Bigl, Volker ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Aging; Animal model; Cortex; Hyperphosphorylation; Microtubule associated protein tau

Indexed keywords

MONOCLONAL ANTIBODY; TAU PROTEIN;

AGING; ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; BABOON; BEAR; BRAIN CORTEX; BUFFALO; DEER; DEGENERATIVE DISEASE; DOMESTIC ANIMAL; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPUS; IMMUNOREACTIVITY; MALE; MAMMAL; MOTOR CORTEX; NERVE CELL; NEUROFIBRILLARY TANGLE; NEUROPIL THREAD; NONHUMAN; PERIKARYON; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RABBIT; RHESUS MONKEY;

EID: 0342626774     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010000183     Document Type: Article

References (55)

1. Arendt T, Holzer M, Fruth R, Brückner MK, Gärtner U (1998) Phosphorylation of tau, Aβ-formation, and apoptosis after in vivo inhibition of PP-1 and PP-2 A. Neurobiol Aging 19:3-13
2. Bancher C, Brunner C, Lassmann H, Budka H, Jellinger K, Wiche G, Seitelberger F, Grundke-Iqbal I, Iqbal K, Wisniewski HM (1989) Accumulation of abnormally phosphorylated τ precedes the formation of neurofibrillary tangles. Brain Res 477: 90-99
3. Bierer LM, Hof PR, Purohit DP, Carlin L, Schmeidler J, Davis KL, Perl DP (1995) Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch Neurol 52:81-88
4. Biernat J, Mandelkow E-M, Schröter C, Lichtenberg-Kraag B, Steiner B, Berling B, Meyer H, Mercken M, Vandermeeren A, Goedert M, Mandelkow E (1992) The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region. EMBO J 11:1593-1597
5. Billingsley ML, Kincaid RL (1997) Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochem J 323:577-591
6. Bondareff W, Harrington C, Wischik CM, Hauser DL, Roth M (1994) Immunohistochemical staging of neurofibrillary degeneration in Alzheimer's disease. J Neuropathol Exp Neurol 53: 158-164
7. Bons N, Mestre N, Petter A (1991) Senile plaques and neurofibrillary changes in the brain of aged lemurian primate, Microcebus murinus. Neurobiol Aging 13:99-105
8. Bons N, Jallageas V, Silhol S, Mestre-Frances N, Petter A, Delacourte A (1995) Immunocytochemical characterization of tau proteins during cerebral aging of the lemurian primate Microcebus murinus. C R Acad Sci (Paris) 318:77-83
9. Bons N, Jallageas V, Mestre-Francés N, Silhol S, Petter A, Delacourte A (1995) Microcebus murinus, a convenient laboratory animal model for the study of Alzheimer's disease. Alzheimer Res 1:83-87
10. Braak E, Braak H, Mandelkow E-M (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87:554-567
11. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259
12. Braak H, Braak E (1996) Evolution of the neuropathology of Alzheimer's disease. Acta Neurol Scand Suppl 165:3-12
13. Braak H, Braak E, Strothjohann M (1994) Abnormally phosphorylated tau protein related to the formation of neurofibrillary tangles and neuropil threads in the cerebral cortex of sheep and goat. Neurosci Lett 171:1-4
14. Brion J-P (1998) Neurofibrillary tangles and Alzheimer's disease. Eur Neurol 40:130-140
15. Brückner G, Hausen D, Härtig W, Drlicek M, Arendt T, Brauer K (1999) Cortical areas abundant in extracellular matrix chondroitin sulphate proteoglycans are less affected by cytoskeletal changes in Alzheimer's disease. Neuroscience 92:791-805
16. Cork LC, Powers RE, Selkoe DJ, Davies P, Geyer JJ, Price DL (1988) Neurofibrillary tangles and senile plaques in aged bears. J Neuropathol Exp Neurol 47:629-641
17. Cork LC, Walker LC, Price DL (1989) Neurofibrillary tangles and senile plaques in a cognilively impaired, aged nonhuman primate. J Neuropathol Exp Neurol 48:378
18. Cummings BJ, Head E, Ruehl W, Milgram NW, Cotman CW (1996) The canine as an animal model of human aging and dementia. Neurobiol Aging 17:259-268
19. Flindt R (1995) Biologie in Zahlen. Gustav Fischer, Stuttgart, pp 6-8
20. Gärtner U, Janke C, Holzer M, Vanmechelen E, Arendt T (1999) Postmortem changes in the phosphorylation state of tau protein in rat brain. Neurobiol Aging 19:535-543
21. Gertz H-J, Xuereb J, Huppert F, Brayne C, McGee MA, Paykel E, Harrington C, Mukaetova-Ladinska E, Arendt T. Wischik CM (1998) Examination of the validity of the hierarchical model of neuropathological staging in normal aging and Alzheimer's disease. Acta Neuropathol 95:154-158
22. Giannakopoulos P, Silhol S, Jallageas V, Mallet J, Bons N, Bouras C, Delaère P (1997) Quantitative analysis of tau protein-immunoreactive accumulations and β amyloid protein deposits in the cerebral cortex of the mouse lemur, Microcebus murinus. Acta Neuropathol 94:131-139
23. Goedert M (1993) Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci 16:460-465
24. Goedert M, Jakes R, Vanmechelen E (1995) Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 189:167-170
25. Goedert M, Spillantini MG, Hasegawa M, Jakes R, Crowther RA, Klug A (1996) Molecular dissection of the neurofibrillary lesions of Alzheimer's disease. Cold Spring Harbor Symp Quant Biol 61:565-573
26. Götz J. Probst A, Spillantini MG, Schäfer T, Jakes R, Bürki K, Goedert M (1995) Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. EMBO J 14: 1304-1313
27. Greenberg SG, Davies P, Schein JD, Binder LI (1992) Hydrofluoric acid-treated τ PHF proteins display the same biochemical properties as normal τ. J Biol Chem 267:564-569
28. Härtig W, Brückner G, Holzer M, Brauer K, Bigl V (1995) Digoxigenylated primary antibodies for sensitive dual-peroxidase labelling of neuronal markers. Histochem Cell Biol 104: 467-472
29. Härtig W, Brückner G, Schmidt C, Brauer K, Bodewitz G, Turner JD, Bigl V (1997) Co-localization of β-amyloid peptides, apolipoprotein E and glial markers in senile plaques in the prefrontal cortex of old rhesus monkeys. Brain Res 751: 315-322
30. Härtig W, Schmidt C, Brauer K, Schüppel K-F, Arendt T, Bigl V, Brückner G (1997) Screening for β-amyloid- and AT8-immunoreactivity and its relationship to specialized forms of extracellular matrix in old animals. Soc Neurosci Abstr 23: 1646
31. Härtig W, Schmidt C, Brauer K, Schüppel K-F, Arendt T, Bigl V, Brückner G (1998) β-amyloid deposits and hyperphosphorylated neurofilaments in aged mammals: no correlation with perineuronal net components. In: Wehner R, Elsner N (eds) Proceedings of the 26th Göttingen Neurobiology Conference 1998. Georg Thieme, Stuttgart, p 735
32. Hof PR (1997) Morphology and neurochemical characteristics of the vulnerable neurons in brain aging and Alzheimer's disease. Eur Neurol 37:71-81
33. Iqbal K, Alonso A del C, Gong C-X, Khatoon S, Pei J-J, Wang JZ, Grundke-Iqbal I (1998) Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles. J Neural Transm Suppl 53:169-180
34. Janke C, Beck M, Stahl T, Holzer M, Brauer K, Bigl V, Arendt T (1999) Phylogenetic diversity of the expression of the microtubule-associated protein tau: implications for neurodegenerative disorders. Mol Brain Res 68:119-128
35. Jicha GA, Lane E, Vincent I, Otvos L Jr, Hoffmann R, Davies P (1997) A conformation- and phosphorylation-dependent antibody recognizing paired helical filaments of Alzheimer's disease. J Neurochem 69:2087-2095
36. Matsuo ES, Shin RW, Billingsley ML, Vandevoorde A, Oconnor M, Trojanowski JQ, Lee VMY (1994) Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron 13:989-1002
37. Mercken M, Vandermeeren M, Lübke U, Six J, Boons J, Vaan de Vorde A, Martin JJ, Gheuens J (1992) Monoclonal antibodies with selective specificity for Alzheimer tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol 84: 265-272
38. Morrison JH, Hof PR (1997) Life and death of neurons in the aging brain. Science 278:412-419
39. Nelson PT, Saper CB (1995) Ultrastructure of neurofibrillary tangles in the cerebral cortex of sheep. Neurobiol Aging 16: 315-323
40. Nelson PT, Saper CB (1996) Injections of okadaic acid, but not beta-amyloid peptide, induce Alz-50 immunoreactive dystrophic neuntes in the cerebral cortex of sheep. Neurosci Lett 208:77-80
41. Nelson PT, Greenberg S, Saper CB (1994) Neurofibrillary tangles in the cerebral cortex of sheep. Neurosci Lett 170: 187-190
42. Otvos L Jr, Feiner L, Lang E, Szendrei GI, Goedert M, Lee VM (1994) Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J Neurosci Res 39:669-673
43. Peters A, Rosene DL, Moss MB, Kemper TL, Abraham CR, Tigges J, Albert MS (1996) Neurobiological bases of age-related cognitive decline in the rhesus monkey. J Neuropathol Exp Neurol 55:861-874
44. Price DL, Martin LJ, Clatterbuck RE, Koliatsos VE, Sisodia SS, Walker LC, Cork LC (1992) Neuronal degeneration in human diseases and animal models. J Neurobiol 23:1277-1294
45. Probst A, Tolnay M, Langui D, Goedert M, Spillantini MG (1996) Pick's disease: hyperphosphorylated tau protein segregates to the somatoaxonal compartment. Acta Neuropathol 92: 588-596
46. Roertgen KE, Parisi JE, Clark HB, Barnes DL, O'Brien TD, Johnson KH (1996) Aβ-associated cerebral angiopathy and senile plaques with neurofibrillary tangles and cerebral hemorrhage in an aged wolverine (Gulo gulo). Neurobiol Aging 17: 243-247
47. Savory J, Huang Y, Herman MM, Wills MR (1996) Quantitative image analysis of temporal changes in tau and neurofilament proteins during the course of acute experimental neurofibrillary degeneration: non phosphorylated epitopes precede phosphorylation. Brain Res 707:272-281
48. Schultz C, Braak E, Braak H (1998) A nonhuman primate model for tau-positive cytoskeletal pathology affecting neurons, astrocytes, and oligodendrocytes. Clin Neuropathol 17: 251
49. Schwab C, Bondada V, Sparks DL, Cahan LD, Geddes JW (1994) Postmortem changes in the levels and localization of microtubule-associated proteins (tau, MAP2 and MAP1B) in the rat and human hippocampus. Hippocampus 4:210-225
50. Singer SM, Chambers CB, Newfry GA, Norlund MA, Muma NA (1997) Tau in aluminium-induced neurofibrillary tangles. Neurotoxicology 18:63-76
51. Su JH, Cummings BJ, Cotman CW (1994) Early phosphorylalion of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neuntes. NeuroReport 5:2358-2362
52. Uno H, Walker LC (1993) The age of biosenescence and the incidence of cerebral β-amyloidosis in aged captive rhesus monkeys. Ann NY Acad Sci 695:232-235
53. Van der Zee EA, Naber PA, Disterhoft JF (1997) Age-dependent changes in the immunoreactivity for neurofilaments in rabbit hippocampus. Neuroscience 79:103-116
54. Vincent I, Rosado M, Davies P (1996) Mitotic mechanisms in Alzheimer's disease? J Cell Biol 132:413-425
55. Zheng-Fischhöfer Q, Biernat J, Mandelkow E-M, Illenberger S, Godemann R, Mandelkow E (1998) Sequential phosphorylation of Tau by glycogen synthase kinase-3 β and protein kinase A at Thr 212 and Ser 214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation. Eur J Biochem 252:542-552